10 INTERNATIONAL NEWS Dental Tribune Japan Edition | 4/2019 ADA By Dental Tribune International ADA ADA ADA 161,000 ADA1 NSAIDs アメリカ歯科医師会は、急性疼痛管理の1次治療として、歯科医はオピオイド(麻 薬性鎮痛剤)を処方するのではなく、非ステロイド性抗炎症薬(NSAIDs)を検討す べきと考えている(写真:KieferPix/Shutterstock社) AD ADA 20183ADA 7 ADA 4ADA e Journal of the American Dental Association NSAIDs ADA News Americas 2018/12/31 DENTAL TRIBUNE 2019 Vol.3 No.1 ............... ............... ....... ....... ........... ................... dti ..... ... 2019410 1510072 13414 3 International Office/Headquarters Publisher/Chief Executive Officer Torsten R. Oemus Chief Financial Officer Dan Wunderlich Director of Content Claudia Duschek Business Development & Marketing Manager Alyson Buchenau Sales & Production Support Puja Daya Hajir Shubbar Madleen Zoch Executive Producer Gernot Meyer Advertising Disposition Marius Mezger Dental Tribune International GmbH Holbeinstr. 29, 04229 Leipzig, Germany Tel.: +49 341 48 474 302 | Fax: +49 341 48 474 173 info@dentaltribune.com | www.dentaltribune.com info@blancnet.co.jp ©2019, Dental Tribune International GmbH. All rights reserved. Dental Tribune International makes every effort to report clinical information and manufacturers product news accurately, but cannot assume responsibility for the validity of product claims, or for typographical errors. e publishers also do not assume responsibility for product names, claims, or statements made by advertisers. Opinions expressed by authors are their own and may not reflect those of Dental Tribune International. PRINT EVENTS EDUCATION DIGITAL SERVICES Dental Tribune International The World's Dental Marketplace www.dental-tribune.com